Unlocking Immune Potential: Ruxolitinib Enhances Checkpoint Blockade Therapy in Cancer Treatment
Checkpoint inhibitor therapies can be likened to releasing the molecular “brake” on the immune system. These drugs eliminate protein barriers that typically hinder the immune system from identifying and attacking … Read More